(PRWEB) December 27, 2012
The US Drug Watchdog says, "We do not think most family members of a diabetic, who was using the diabetes drug called Actos, and then developed fatal bladder cancer are aware there could be a relationship between Actos, and the bladder cancer, but that is exactly what we are saying. We are requesting the family members of a diabetic to check, and see if he, or she had used, or was using the diabetes drug called Actos prior to being diagnosed with bladder cancer. If the answer is yes, we want the family members to call the Johnson law firm immediately." The US Drug Watchdog does not think many diabetics would ever consider a diabetes drug could be related to bladder cancer, but in the case of the diabetes drug called Actos, this is exactly what the group fears may have happened. Again, if a family is morning the loss of a loved one who had diabetes, who was using the diabetes drug called Actos, and died from bladder cancer the US Drug Watchdog is urging them to contact the Johnson Law Group at 1-800-996-9900. http://www.johnsonlawgroup.com/
According to the AP, "The FDA has issued a warning that Actos may be linked to an increased risk of bladder cancer. Meanwhile, both Germany and France have suspended sales of Actos. The Actos suspension became effective July 11, 2011. Actos, along with another diabetes drug made by Takeda Pharmaceutical, Competact, came under fire in Europe after a study revealed an increased risk for bladder cancer among diabetes patients who used the medication." The US Drug Watchdog says, "We want any user of the diabetes medication called Actos, who then developed bladder cancer to call the Johnson Law Group at 1-800-996-9900. Time really is of the essence." For more information about the Johnson Law group please visit their web site at http://USDrugWatchdog.Com
Case number 11cv2406 BEN BGS in the Federal District Court San Diego, CA.
Read the full story at http://www.prweb.com/releases/2012/12/prweb10259115.htm.
Copyright©2012 Vocus, Inc.
All rights reserved